Alzamend Neuro reported total assets of $2.08M and total liabilities of $1.35M for the quarter ended Apr 2026, down 54.8% year over year. This balance sheet covers 25 quarters of results from Apr 2020 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables - AccuredAcc. Int. Receivables | |||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 15.62M | 13.57M | 11.79M | 11.53M | 9.18M | 7.38M | 5.14M | 1.70M | 0.20M | 0.28M | 0.38M | 1.19M | 4.09M | 3.36M | 3.95M | 5.62M | 4.45M | 2.71M | 0.71M | ||||||
| Receivables - OtherOther Receivables | 0.02M | 0.02M | 0.01M | ||||||||||||||||||||||
| Prepaid Assets | 0.35M | 0.93M | 0.64M | 0.35M | 0.59M | 0.74M | 0.55M | 0.45M | 0.72M | 0.58M | 0.31M | 0.08M | 0.22M | 0.67M | 0.59M | 0.23M | 0.31M | 0.27M | 0.99M | 1.05M | |||||
| Current Assets | 16.82M | 14.50M | 12.43M | 14.41M | 12.11M | 10.33M | 8.42M | 5.84M | 2.41M | 0.78M | 0.59M | 0.46M | 1.42M | 4.77M | 3.95M | 4.18M | 5.93M | 4.72M | 3.70M | 1.76M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.10M | 0.10M | 0.09M | 0.09M | 0.08M | 0.21M | 0.20M | 0.19M | 0.18M | 0.25M | 0.24M | 0.23M | 0.43M | 0.40M | 0.37M | 0.34M | 0.31M | ||||||||
| Long-Term Deferred Tax | 10.10M | ||||||||||||||||||||||||
| Non-Current Assets | 0.10M | 0.10M | 0.09M | 0.09M | 0.08M | 0.21M | 0.20M | 0.19M | 0.18M | 0.25M | 0.24M | 0.23M | 0.43M | 0.40M | 0.37M | 0.34M | 0.31M | ||||||||
| Assets | 16.82M | 14.50M | 12.43M | 14.52M | 12.21M | 10.42M | 8.50M | 5.92M | 2.63M | 0.98M | 0.78M | 0.63M | 1.67M | 5.01M | 4.18M | 4.60M | 6.33M | 5.09M | 4.04M | 2.08M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 1.07M | 1.13M | 0.46M | 1.16M | 1.03M | 0.65M | 2.64M | 2.87M | 2.74M | 3.67M | 3.83M | 2.93M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.86M | 1.35M | |||||
| Notes Payables | 0.06M | 0.00M | 0.00M | 0.00M | 0.99M | 0.30M | |||||||||||||||||||
| Payables | 1.13M | 1.13M | 0.47M | 1.16M | 1.03M | 1.64M | 2.64M | 2.87M | 2.74M | 3.67M | 3.83M | 3.23M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.86M | 1.35M | |||||
| Total Current Liabilities | 1.47M | 1.48M | 0.47M | 1.16M | 1.03M | 1.64M | 2.64M | 2.87M | 3.83M | ||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Convertible Debt | 0.34M | 0.34M | |||||||||||||||||||||||
| Non-Current Deffered Revenue | 0.74M | ||||||||||||||||||||||||
| Preferred Stock Liabilities | 0.48M | ||||||||||||||||||||||||
| Non-Current Deferred Tax Liability | 0.03M | 0.02M | 0.01M | ||||||||||||||||||||||
| Total Liabilities | 1.47M | 1.48M | 0.47M | 1.16M | 1.03M | 1.64M | 2.64M | 2.87M | 2.74M | 3.67M | 4.57M | 3.23M | 2.88M | 1.25M | 0.73M | 0.63M | 0.98M | 0.72M | 1.86M | 1.35M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Total Debt | 0.06M | 0.00M | 0.00M | 0.00M | 0.99M | 0.30M | |||||||||||||||||||
| Common Equity | 15.34M | 13.03M | 11.96M | 13.35M | 11.18M | 8.79M | 5.86M | 3.05M | -0.11M | -2.68M | -4.26M | -2.59M | -1.21M | 3.75M | 3.45M | 3.97M | 5.34M | 4.37M | 2.20M | 0.73M | |||||
| Liabilities and Shareholders Equity | 16.82M | 14.50M | 12.43M | 14.52M | 12.21M | 10.42M | 8.50M | 5.92M | 2.63M | 0.98M | 0.78M | 0.63M | 1.67M | 5.01M | 4.18M | 4.60M | 6.33M | 5.09M | 4.04M | 2.08M | |||||
| Retained Earnings | 49.37M | 50.65M | 52.16M | 57.42M | 58.29M | 59.00M | 61.50M | 62.00M | 62.36M | 62.70M | -53.17M | -54.02M | -54.99M | 60.16M | 60.85M | 62.50M | 66.58M | 66.61M | 66.62M | 68.04M | |||||
| Preferred Shares | 10.00M |